These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39024506)

  • 1. A budget impact analysis of gene therapy for sickle cell disease: an updated analysis.
    DeMartino PC; Haag MB; Caughey AB; Roth JA
    Blood Adv; 2024 Sep; 8(17):4658-4661. PubMed ID: 39024506
    [No Abstract]   [Full Text] [Related]  

  • 2. Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease.
    Abdallah K; Huys I; Claes KJ; Simoens S
    Clin Drug Investig; 2024 Aug; 44(8):611-627. PubMed ID: 39134876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective.
    DeMartino P; Haag MB; Hersh AR; Caughey AB; Roth JA
    JAMA Pediatr; 2021 Jun; 175(6):617-623. PubMed ID: 33749717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dismantling cost and infrastructure barriers to equitable access to gene therapies for sickle cell disease.
    Sharma A; John TD
    Lancet Haematol; 2024 Aug; 11(8):e556-e559. PubMed ID: 38964356
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy is facing its biggest challenge yet.
    Ledford H
    Nature; 2019 Dec; 576(7785):22-25. PubMed ID: 31797915
    [No Abstract]   [Full Text] [Related]  

  • 6. The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease.
    Cliff ERS; Tessema FA
    JAMA; 2024 Sep; 332(9):703-704. PubMed ID: 39102257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expensive treatments for genetic disorders are arriving. But who should foot the bill?
    Nature; 2019 Dec; 576(7785):7-8. PubMed ID: 31797916
    [No Abstract]   [Full Text] [Related]  

  • 8. Affordable HIV and sickle cell disease gene therapies.
    Mullard A
    Nat Rev Drug Discov; 2019 Nov; 18(12):895. PubMed ID: 31780850
    [No Abstract]   [Full Text] [Related]  

  • 9. Promising gene therapies pose million-dollar conundrum.
    Check Hayden E
    Nature; 2016 Jun; 534(7607):305-6. PubMed ID: 27306167
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy targets sickle-cell disease.
    Nowogrodzki A
    Nature; 2018 Dec; 564(7735):S12-S13. PubMed ID: 30542183
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy renews hope to lower the global rural sickle cell disease burden.
    Tachere RO; Umunna AO
    Rural Remote Health; 2017; 17(3):4291. PubMed ID: 28877587
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy for sickle cell disease.
    The Lancet Haematology
    Lancet Haematol; 2016 Oct; 3(10):e446. PubMed ID: 27692301
    [No Abstract]   [Full Text] [Related]  

  • 13. Welcoming the Era of Gene Editing in Medicine.
    Daley GQ
    N Engl J Med; 2024 May; 390(18):1642-1645. PubMed ID: 38657270
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gene therapy for sickle cell disease].
    Ribeil JA; Blanche S; Cavazzana M
    Med Sci (Paris); 2017 May; 33(5):463-465. PubMed ID: 28612714
    [No Abstract]   [Full Text] [Related]  

  • 15. An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States.
    Wesevich A; Peek ME; Ratain MJ
    Ann Intern Med; 2024 Jan; 177(1):85-86. PubMed ID: 38048579
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell and gene therapy accessibility.
    Rouce RH; Porteus MH
    Science; 2024 Aug; 385(6708):475. PubMed ID: 39088615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophilia.
    Bollard CM
    Blood; 2021 Sep; 138(11):913. PubMed ID: 34232977
    [No Abstract]   [Full Text] [Related]  

  • 18. A Surprising Fix for Sickle Cell.
    Weintraub K
    Sci Am; 2016 May; 314(5):24-26. PubMed ID: 27100249
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy for sickle cell disease: where we are now?
    Kanter J; Falcon C
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):174-180. PubMed ID: 34889358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy: editorial control.
    Gammon K
    Nature; 2014 Nov; 515(7526):S11-3. PubMed ID: 25390136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.